Overseed
Overseed is the first French biotech company to obtain its license from the ANSM to start its R&D process on cannabis production for pharmaceutical purposes. We are a Biotech which combines leading expertise in genetics, agronomy, organic chemistry and pharma with the ambition to have an expert knowledge on the production of therapeutic cannabis. We will produce GACP and GMP certified dried flowers, full spectrum extracts and purified pharmaceutical grade active ingredients for laboratories. Overseed's research and experimentation will answer patients and the health industry expectations to guarantee production sovereignty, proximity of collaborations and certified quality of cultivated products, in direct connection with medical and scientific studies. Patient-driven, the culture of Overseed is based on people, product quality and value creation.
Growth Trajectory
The company is positioned for growth through the development of production and research on cannabinoids for medical applications, focusing on dried flowers, full-spectrum extracts, and purified active ingredients. They aim to meet the expectations of patients and the healthcare industry, indicating market expansion and new product developments driven by R&D in cannabis production.
Technical Challenges
Tech Stack
Team Size
Key Risks
Opportunities
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats